21 CFR § 333.280
Professional labeling
June 25, 2020
The labeling provided to health professionals (but not to the general public) may contain the following additional indication:
(a) For products containing haloprogin or miconazole nitrate identified in §333.210 (a) and (c). “For the treatment of superficial skin infections caused by yeast (Candida albicans).”
(b) [Reserved]